Anterios' Series B - III Round

Anterios raised a round of funding on September 06, 2010.

Anterios, formerly Encapsion, is a privately held, clinical-stage biopharmaceutical company that is developing next-generation botulinum-based prescription products for medical dermatology and aesthet…

Articles about Anterios' Series B - III Round: